ORCHESTRA BIOMED HOLDINGS INC. - ORDINARY SHARES

Orchestra BioMed to Present at Upcoming Investor Conferences

20 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

18 Feb 2025 08:00:01 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

12 Feb 2025 10:43:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

05 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

09 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

26 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

12 Nov 2024 16:12:39 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

07 Nov 2024 08:00:01 By Nasdaq GlobeNewswire

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

12 Aug 2024 16:20:20 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

30 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

04 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

22 May 2024 08:43:18 By Nasdaq GlobeNewswire

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

13 May 2024 16:58:13 By Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

30 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

30 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

27 Mar 2024 16:17:23 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

26 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting

13 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Upcoming Investor Conferences

07 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients

06 Mar 2024 08:37:17 By Nasdaq GlobeNewswire